Before Markup

Tissue Classifier Add-on

Leverage the random forest machine learning algorithm behind the Tissue Classifier Add-on for HALO® to quickly and automatically identify tissue types based on color, texture, and contextual features. This add-on features an intuitive “learn-by-example” approach and can categorize tissues within seconds after the user highlights a few distinct tissue types. The Tissue Classifier Add-on is embedded in the HALO platform and can be used in conjunction with any cell-based analysis module for brightfield or fluorescence analysis.

Try it out! Click here to initiate your free proof-of-concept HALO image analysis.

File formats supported by the HALO image analysis platform:

  • Non-proprietary (JPG, TIF, OME.TIFF)
  • Nikon (ND2)
  • 3D Histech (MRXS)
  • Akoya (QPTIFF, component TIFF)
  • Olympus / Evident (VSI)
  • Hamamatsu (NDPI, NDPIS)
  • Aperio (SVS, AFI)
  • Zeiss (CZI)
  • Leica (SCN, LIF)
  • Ventana (BIF)
  • Philips (iSyntax, i2Syntax)
  • KFBIO (KFB, KFBF)
  • DICOM (DCM*)
    *whole-slide images

HALO AI Whitepaper

Check out this white paper for an in-depth introduction to the deep learning-based add-on to HALO, including available networks, common functions, and the “train – validate – test” Validation workflow.

View »

Publication Spotlight

The table below includes publications that cite the Tissue Classifier Add-on. 

Your publication not on the list?  Drop us an email to let us know about it!

TitleAuthorsYearJournalTopicsHALO ModulesProducts
Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentationEstephan H, Tailor A, Parker R, Kreamer M, Papandreou I, Campo L, Easton A, Moon EJ, Denko NC, Ternette N, Hammond EM, Giaccia AJ2025The EMBO JournalImmuno-oncologyClassifier, Area Quantification, Spatial Analysis, Highplex FLHALO
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial)Ressler J M, Plaschka M, Silmbrod R, Bachmayr V, Shaw L E, Silly T, Zila N, Stepan A, Kusienicka A, Tschandl P, Tittes J, Roka F, Haslik W, Petzelbauer P, Koenig F, Kunstfeld R, Farlik M, Halbritter F, Weninger W, Hoeller C2025Nature CancerOncologyClassifier, Spatial Analysis, Highplex FLHALO
A multistage drug delivery approach for colorectal primary tumors and lymph node metastasesYuan Y, Lin Q, Feng HY, Zhang Y, Lai X, Zhu MH, Wang J, Shi J, Huang Y, Zhang L, Lu Q, Yuan Z, Lovell JF, Chen HZ, Sun P, Fang C2025Nature CommunicationsOncologyClassifier, Area Quantification, Spatial AnalysisHALO
Endothelial cell pY397-FAK expression predicts risk of breast cancer recurrences after radiotherapy in SweBCG91-RT cohortDrake R J, Landén A H, Holmberg E, Stenmark Tullberg A, Killander F, Niméus E, Jordan A, McGuinness J, Karlsson P, Hodivala-Dilke K2025Clinical Cancer ResearchOncologyClassifier, Area QuantificationHALO
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanismsSivakumar S, Jainarayanan A, Arbe-Barnes E, Sharma P K, Leathlobhair M N, Amin S, Reiss D J, Heij L, Hegde S, Magen A, Tucci F, Sun B, Wu S, Anand N M, Slawinski H, Revale S, Nassiri I, Webber J, Hoeltzel G D, Frampton A E, Wiltberger G, Neumann U, Charlton P, Spiers L, Elliott T, Wang M, Couto S, Lila T, Sivakumar P V, Ratushny A V, Middleton M R, Peppa D, Fairfax B, Merad M, Dustin M L, Abu-Shah E, Bashford-Rogers R2025Nature CommunicationsImmuno-oncologyClassifier, Multiplex IHC, RegistrationHALO
Dietary Oxidized Lipids in Redox Biology: Oxidized Olive Oil Disrupts Lipid Metabolism and Induces Intestinal and Hepatic Inflammation in C57BL/6J MiceBao Y, Osowiecka M, Ott C, Tziraki V, Meusburger L, Blaßnig C, Krivda D, Pjevac P, Silva J, Strauss M, Steffen C, Heck V, Aygün S, Duszka K, Doppelmayer K, Grune T, Pignitter M2025Redox BiologyMetabolismClassifier, Area QuantificationHALO
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trialAronson S L, Thijssen B, Lopez-Yurda M, Koole S N, van der Leest P, León-Castillo A, Harkes R, Seignette I M, Sanders J, Alkemade M, Kemper I, Holtkamp M J, Mandjes I A M, Broeks A, Lahaye M J, Rijlaarsdam M A, van den Broek D, Wessels L F A, Horlings H M, van Driel W J, Sonke G S2025Nature CommunicationsImmuno-oncologyClassifier, Highplex FLHALO
Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting responseAlcindor T, Tankel J, Fiset P-O, Pal S, Opu T, Strasser M, Dehghani M, Bertos N, Zuo D, Mueller C, Cools-Lartigue J, Hickeson M, Marcus V, Camilleri-Broet S, Spatz A, Evaristo G, Farag M, Artho G, Elkrief A, Saleh R, Bailey S, Park M, Huang S, Sangwan V, Ferri L2025Cell Reports MedicineImmuno-oncologyClassifier, Spatial Analysis, Highplex FLHALO
Stromal lipid species dictate melanoma metastasis and tropismGurung S, Budden T, Mallela K, Jenkins B, von Kriegsheim A, Manrique E, Millán-Esteban D, Romero-Camarero I, Amaral F, Craig S, Durao P, Pozniak J, Stennett L, Smith D, Ashton G, Baker A, Zeng K, Fruhwirth G, Sanz-Moreno V, Marques J, Koulman A, Marine J-C, Somervaille T C P, Motta L, Gaudy-Marqueste C, Nagore E, Virós A2025Cancer CellOncologyClassifierHALO
Profiling triple-negative breast cancer-specific super-enhancers identifies high-risk mesenchymal development subtype and BETi-Targetable vulnerabilitiesChen Q, Cai R, Wang Y, Liang G, Zhang K, Yang X, Yang D, Zhao D, Zhu X, Deng R, Tang J2025Molecular CancerOncologyClassifier, Cytonuclear, Highplex FLHALO
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibromaAbu-Sultanah M, Zhou Z, Jiang C, Mitchell D K, Bessler W K, Jiang L, Li X, Qian S, Smith A E, Mang H E, White E E, Ciesielski M D, Hickey B E, Brewster K M, Sandusky G E, Masters A, Angus S P, Clapp D W, Le L Q, Rhodes S D2025Science AdvancesNeuroscienceClassifier, Area QuantificationHALO
Hepatic zonation determines tumorigenic potential of mutant β-cateninRaven A, Gilroy K, Jin H, Waldron J, Leslie H, Munro J, Hall H, Ridgway R, Ford C, Gulhan D, Vlahov N, Mills M, Hartley A, Anderson E, Bryson S, Sphyris N, Müller M, May S, Cadden B, Nixon C, Waddell S, Guest R, Boulter L, Barker N, Clevers H, Zhu H, Ivaska J, Strathdee D, Miller C, Jamieson N, Bushell M, Park P, Bird T, Sansom O2025NatureOncologyClassifier, Area Quantification, Highplex FLHALO
HIF‐1 Targeting Intervention Renders Protection From Alzheimer’s‐Like Pathology in a Humanized Mice Model of HIV InfectionRay S, Kumar M, Chemparathy DT, Dash PK, Sil S2025Journal of Extracellular VesiclesNeuroscienceClassifierHALO
Single-cell multi-omics analysis revealed the expansion of age-associated B cells in the pancreas of type 1 autoimmune pancreatitis patientsWang J, Liu C, Zhang X, Che T, Zhao Y, Yang Q, Qin X, Chen Y, Ao X, Shen X, He X, Gong T, Zhang L, Zhang M, Wang D, Du Y, Wen L, Ye Y, Zhang Y, Zhou C, Zou D2025Genome MedicineImmunologyClassifier, Spatial Analysis, Highplex FLHALO
The swine IsoLoop model of the gut host-microbiota interface enables intra-animal treatment comparisons to advance 3R principlesBayne J, Charavaryamath C, Hu Y, Yousefi F, Murphy M, Law A, Michael A, Muyyarikkandy M, Nibbering B, Smits W, Kuijper E, Opriessnig T, Sauer M, Scaria J, Sponseller B, Ramirez A, Mooyottu S2025Gut MicrobesInfectious DiseaseClassifierHALO
SFPQ-TFE3 reciprocally regulates mTORC1 and induces lineage plasticity in a mouse model of renal tumorigenesisKaushal Asrani, Adrianna Amaral, Juhyung Woo, Sanaz Nourmohammadi Abadchi, Thiago Vidotto, Eddie Imada, Alyza Skaist, Kewen Feng, Hans B. Liu, Mithila Kasbe, Yorifumi Satou, Masaya Baba, Yuichi Oike, Patricia Outeda, Terry Watnick, Avi Z. Rosenberg, Laura S. Schmidt, W. Marston Linehan, Pedram Argani & Tamara L. Lotan2025Nature CommunicationsOncologyClassifier, CytonuclearHALO
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA responseZhao M, Wang T, Gleber-Netto F O, Chen Z, McGrail D J, Gomez J A, Ju W, Gadhikar M A, Ma W, Shen L, Wang Q, Tang X, Pathak S, Raso M G, Burks J K, Lin S-Y, Wang J, Multani A S, Pickering C R, Chen J, Myers J N, Zhou G2024Nature CommunicationsOncologyClassifierHALO
Early immune remodeling steers clinical response to frontline chemoimmunotherapy in advanced gastric cancerAn M, Mehta A, Min BH, Geo YJ, Wright SJ, Parikh M, Bi L, Lee H, Kim TJ, Lee SY, Moon J, Park RJ, Strickland MR, Park WY, Kang WK, Kim KM, Kim ST, Lempner SJ, Lee J2024Cancer DiscoveryImmuno-oncologyClassifier, Highplex FLHALO
Nanoparticle mediated photodynamic therapy as a method to ablate oral cavity squamous cell carcinoma in preclinical modelsSahovaler A, Valic M, Townson J, Chan H, Zheng M, Tzelnick S, Mondello T, Pener-Tessler A, Eu D, El-Sayes A, Ding L, Chen J, Douglas C, Weersink R, Muhanna N, Zheng G, Irish J2024Cancer ResearchOncologyClassifier, Multiplex IHCHALO
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJiang J, Jiang L, Maldonato B J, Wang Y, Holderfield M, Aronchik I, Winters I P, Salman Z, Blaj C, Menard M, Brodbeck J, Chen Z, Wei X, Rosen M J, Gindin Y, Lee B J, Evans J W, Chang S, Wang Z, Seamon K J, Parsons D, Cregg J, Marquez A, Tomlinson A C A, Yano J K, Knox J E, Quintana E, Aguirre A J, Arbour K C, Reed A, Gustafson W C, Gill A L, Koltun E S, Wildes D, Smith J A M, Wang Z, Singh M2024Cancer DiscoveryOncologyClassifier, Area Quantification, CytonuclearHALO
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancerKasikova L, Rakova J, Hensler M, Lanickova T, Tomankova J, Pasulka J, Drozenova J, Mojzisova K, Fialova A, Vosahlikova S, Laco J, Ryska A, Dundr P, Kocian R, Brtnicky T, Skapa P, Capkova L, Kovar M, Prochazka J, Praznovec I, Koblizek V, Taskova A, Tanaka H, Lischke R, Mendez F C, Jr J V, Heinzelmann-Schwarz V, Jacob F, McNeish I A, Halaska M J, Rob L, Cibula D, Orsulic S, Galluzzi L, Spisek R, Fucikova J2024Nature CommunicationsOncologyClassifier, Highplex FL, RegistrationHALO
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate CancerBoufaied N, Chetta P, Hallal T, Cacciatore S, Lalli D, Luthold C, Homsy K, Imada E, Syamala S, Photopoulos C, Di Matteo A, de Polo A, Storaci A, Huang Y, Giunchi F, Sheridan P, Michelotti G, Nguyen Q, Zhao X, Liu Y, Davicioni E, Spratt D, Sabbioneda S, Maga G, Mucci L, Ghigna C, Marchionni L, Butler L, Ellis L, Bordeleau F, Loda M, Vaira V, Labbé D, Zadra G2024Cancer ResearchOncologyClassifier, Multiplex IHCHALO
Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumorsRidnour L, Cheng R, Kedei N, Somasundaram V, Bhattacharyya D, Basudhar D, Wink A, Walke A, Kim C, Heinz W, Edmondson E, Butcher D, Warner A, Dorsey T, Pore M, Kinders R, Lipkowitz S, Bryant R, Rittscher J, Wong S, Hewitt S, Chang J, Shalaby A, Callagy G, Glynn S, Ambs S, Anderson S, McVicar D, Lockett S, Wink D2024JCI InsightImmuno-oncologyClassifier, FISH, Spatial Analysis, Highplex FLHALO
Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapyHughes D, Evans A, Go S, Eyres M, Pan L, Mukherjee S, Soonawalla Z, Willenbrock F, O’Neill E2024Science AdvancesImmuno-oncologyClassifier, Spatial Analysis, Highplex FLHALO
Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancerKitai H, Choi P H, Yang Y C, Boyer J A, Whaley A, Pancholi P, Thant C, Reiter J, Chen K, Markov V, Taniguchi H, Yamaguchi R, Ebi H, Evans J, Jiang J J, Lee B, Wildes D, Stanchina E, Smith J A M, Singh M, Rosen N2024Nature CommunicationsOncologyClassifier, Area Quantification, Multiplex IHCHALO
PD‐L1+ macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B‐cell lymphoma microenvironment impact CD19 CAR‐T cell immunotherapy efficacyHirayama A V, Wright J H, Smythe K S, Fiorenza S, Shaw A N, Gauthier J, Maloney D G, Naresh K N, Yeung C C S, Turtle C J2024HemasphereImmuno-oncologyClassifier, Spatial Analysis, Highplex FLHALO, HALO Link
Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfectionSingh B, Sharan R, Ravichandran G, Escobedo R, Shivanna V, Dick E J, Hall-Ursone S, Arora G, Alvarez X, Singh D K, Kaushal D, Mehra S2024JCI InsightInfectious DiseaseClassifier, Highplex FLHALO
Metabolic imaging across scales reveals distinct prostate cancer phenotypesSushentsev N, Hamm G, Flint L, Birtles D, Zakirov A, Richings J, Ling S, Tan J Y, McLean M A, Ayyappan V, Menih I H, Brodie C, Miller J L, Mills I G, Gnanapragasam V J, Warren A Y, Barry S T, Goodwin R J A, Barrett T, Gallagher F A2024Nature CommunicationsOncologyClassifier, Area Quantification, FISH, Membrane, Multiplex IHCHALO, HALO AI
Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancerLanickova T, Hensler M, Kasikova L, Vosahlikova S, Angelidou A, Pasulka J, Griebler H, Drozenova J, Mojzisova K, Vankerckhoven A, Laco J, Ryška A, Dundr P, Kocian R, Cibula D, Brtnicky T, Skapa P, Jacob F, Kovar M, Praznovec I, McNeish I A, Halaska M J, Rob L, Coosemans A, Orsulic S, Galluzzi L, Spisek R, Fucikova J2024Clinical Cancer ResearchImmuno-oncologyClassifier, Highplex FL, RegistrationHALO
Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanomaVos J L, Traets J J H, Qiao X, Seignette I M, Peters D, Wouters M W J M, Hooijberg E, Broeks A, van der Wal J E, Karakullukcu M B, Klop W M C, Navran A, van Beurden M, Brouwer O R, Morris L G T, van Poelgeest M I E, Kapiteijn E, Haanen J B A G, Blank C U, Zuur C L2024JCI InsightImmuno-oncologyClassifier, Spatial Analysis, Highplex FLHALO
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancerChakraborty S, Sen U, Ventura K, Jethalia V, Coleman C, Sridhar S, Banerjee A, Ozakinci H, Mahendravarman Y, Snioch K, Stanchina E, Shields M D, Tomalin L E, Demircioglu D, Boyle T A, Tocheva A, Hasson D, Sen T2024Cell Reports MedicineImmuno-oncologyClassifier, Highplex FLHALO
HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast CancerOlson D, Taylor J, Willis K, Hensley K, Allred S, Zaval M, Farr L, Thurman R, Jain N, Hein R, Ulrich M, Peterson S, Kulukian A2023Cancer Research CommunicationsOncologyClassifier, Multiplex IHCHALO
Cellular mechanisms of heterogeneity in NF2-mutant schwannomaChiasson-MacKenzie C, Vitte J, Liu C, Wright E, Flynn E, Stott S, Giovannini M, McClatchey A2023Nature CommunicationsOncologyClassifier, Multiplex IHC, Spatial Analysis, FISH-IFHALO
Innate immune receptor C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy in tumours with immunosuppressive microenvironmentsBeach C, MacLean D, Majorova D, Melemenidis S, Nambiar D, Kim R, Valbuena G, Guglietta S, Krieg C, Darvish D, Suwa T, Eason A, Domingo E, Moon E, Jiang D, Jiang Y, Koong A, Woodruff T, Graves E, Maughan T, Buczacki S, Stucki M, Le Q-T, Leedham S, Giaccia A, Olcina M2023bioRxivImmuno-oncologyClassifier, Area Quantification, Highplex FLHALO
NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasisIlter D, Drapela S, Schild T, Ward N, Adhikari E, Low V, Asara J, Oskarsson T, Lau E, DeNicola G, McReynolds M, Gomes A2023Redox BiologyOncology, MetabolismClassifier, Highplex FL, TMAHALO
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progressionChen J, Zheng Q, Hicks J, Trabzonlu L, Ozbek B, Jones T, Vaghasia A, Larman T, Wang R, Markowski M, Denmeade S, Pienta K, Hruban R, Antonaraskis E, Gupta A, Dang C, Yegnasubramanian S, De Marzo A2023bioRxivOncologyClassifier, Area Quantification, Serial SectionHALO
PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma PatientsYang X, Wang G, Song Y, Zhuang T, Li Y, Xie Y, Fei X, Zhao Y, Xu D, Hu Y2023CancersOncology, Immuno-oncologyClassifier, Spatial Analysis, Highplex FL, RegistrationHALO
Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b+ macrophage subpopulations and aggravates lung fibrosisMekhael O, Revill S, Hayat A, Cass S, MacDonald K, Vierhout M, Ayoub A, Reihani A, Padwal M, Imani J, Ayaub E, Yousof T, Dvorkin-Gheva A, Rullo A, Hirota J, Richards C, Bridgewater D, Stämpfli M, Hambly N, Naqvi A, Kolb M, Ask K2023Immunology and Cell BiologyImmunology, FibrosisClassifier, Area Quantification, FISH, Multiplex IHCHALO
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cellsBai Y, Gotz C, Chincarini G, Zhao Z, Slaney C, Boath J, Furic L, Angel C, Jane S, Phillips W, Stacker S, Farah C, Darido C2023Nature CommunicationsOncologyClassifier, Multiplex IHCHALO
Prognostic value of tumor immune microenvironment factors in patients with stage I lung adenocarcinomaXue Q, Wang Y, Zheng Q, Chen L, Lin Y, Jin Y, Shen X, Li Y2023American Journal of Cancer ResearchOncologyClassifier, Multiplex IHC, Highplex FLHALO
Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health StudyAbubaker M, Aheam T, Duggan M, Lawrence S, Adjei E, Clegg-Lamptey J, Yamey J, Wiafe-Addai B, Awuah B, Wiafe S, Nyarko K, Aitpillah F, Ansong D, Hewitt S, Brinton L, Figueroa J, Garcia-Closas M, Edusei L, Titiloye N2023Research SquareOncologyClassifier, Multiplex IHCHALO
Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancerSievers C, Craveiro M, Friedman J, Robbins Y, Yang X, Bai K, Nguyen A, Redman J, Chari R, Soon-Shiong P, Schlom J, Gulley J, Allen C.2023Cancer CellImmuno-oncologyClassifier, Highplex FLHALO, HALO AI
Long-Term Fate and Efficacy of a Biomimetic
(Sr)-Apatite-Coated Carbon Patch Used for Bone Reconstruction
Olivier F, Drouet C, Marsan O, Sarou-Kanian V, Rekima S, Gautier N, Fayon F, Bonnamy S, Rochet N2023Journal of Functional BiomaterialsBiomaterialsClassifierHALO
Host, reproductive, and lifestyle factors in relation to quantitative histologic metrics of the normal breastAbubakar M, Klein A, Fan S, Lawrence S, Mutreja K, Henry J, Pfeiffer R, Duggan M, Gierach G2023Research SquareOncologyClassifierHALO, HALO Link
Outdoor air pollution and histologic composition of normal breast tissueIsh J, Abubakar M, Fan S, Jones R, Niehoff N, Henry J, Gierach G, White A2023Environment InternationalOncologyClassifierHALO
Sequential pembrolizumab cooperates with platinum/5FU to remodel the tumor immune microenvironment in advanced gastric cancer: A phase II chemoimmunotherapy trialKlempner S, Lee J, Mehta A, An M, Min B, Heo Y, Parikh M, Bi L, Cristescu R, Lee H, Kim T, Lee S, Moon J, Park R, Strickland M, Park W, Kang W, Kim K, Kim S2023Research SquareImmuno-oncologyClassifier, Highplex FLHALO
Epitope Lability of Phosphorylated Biomarkers of the DNA Damage Response Pathway Results in Increased Vulnerability to Effects of Delayed or Incomplete Formalin FixationWiseman E, Moss J, Atkinson J, Baakza H, Hayes E, Willis S, Waring P, Canales J, Jones G2023Journal of Histochemistry & CytochemistryOtherClassifier, Cytonuclear, Spatial AnalysisHALO
Defective extracellular matrix remodeling in brown adipose tissue is associated with fibro-inflammation and reduced diet-induced thermogenesisPellegrinelli V, Figueroa-Juárez E, Samuelson I, U-Din M, Rodriguez-Fdez S, Virtue S, Leggat J, Çubuk C, Peirce V, Niemi T, Campbell M, Rodriguez-Cuenca S, Dopazo Blázquez J, Carobbio S, Virtanen K, Vidal-Puig A2023Cell ReportsMetabolismClassifier, Area Quantification, VacuoleHALO
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrierTien J, Leonoudakis D, Petrova R, Trinh V, Taura T, Sengupta D, Jo L, Sho A, Yun Y, Doan E, Jamin A, Hallak H, Wilson D, Stratton J2023mAbsNeuroscienceClassifier, Area Quantification, Object ColocalizationHALO
Poor outcome in postpartum breast cancer patients is associated with distinct molecular and immunological featuresLefrère H, Moore K, Floris G, Sanders J, Seignette I, Bismeijer T, Peters D, Broeks A, Hooijberg E, Van Calsteren K, Neven P, Warner E, Peccatori F, Loibl S, Maggen C, Han S, Jerzak K, Annibali D, Lambrechts D, de Visser K, Wessels L, Lenaerts L, Amant F2023Clinical Cancer ResearchOncologyClassifier, Highplex FLHALO, HALO AI
Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosisBurkard T, Herrero San Juan M, Dreis C, Kiprina A, Namgaladze D, Siebenbrodt K, Luger S, Foerch C, Pfeilschifter J, Weigert A, Radeke H2023Clinical and Translational MedicineOncology, ImmunologyClassifier, Spatial Analysis, Highplex FL, TMAHALO
Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancerQuan Y, He J, Zou Q, Zhang L, Sun Q, Huang H, Li W, Xie K, Wie F2023Journal for ImmunoTherapy of CancerImmuno-oncologyClassifier, Multiplex IHC, Highplex FLHALO
Investigating the Effects of Stereotactic Body Radiation Therapy on Pancreatic Tumor Hypoxia and Microvasculature in an Orthotopic Mouse Model using Intravital Fluorescence MicroscopySamuel T, Rapic S, Lindsay P, DaCosta RS2023Research SquareOncologyClassifier, Area QuantificationHALO
Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive marginRuf B, Bruhns M, Babaei S, Kedei N, Ma L, Revsine M, Benmebarek MR, Ma C, Heinrich B, Subramanyam V, Qi J, Wabitsch S, Green BL, Bauer KC, Myojin Y, Greten LT, McCallen JD, Huang P, Trehan R, Wang X, Nur A, Soika DQM, Pouzolles M, Evans CN, Chari R, Kleiner DE, Telford W, Dadkhah K, Ruchinskas A, Stovroff MK, Kang J, Oza K, Ruchirawat M, Kroemer A, Wang XW, Claassen M, Korangy F, Greten TF2023CellImmuno-oncologyClassifier, Spatial Analysis, Highplex FL, Figure MakerHALO
Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancerRobbins Y, Friedman J, Redman J, Sievers C, Lassoued W, Gulley J, Allen C2023Oral OncologyImmuno-oncologyClassifier, Spatial Analysis, Highplex FLHALO
Establishment of reference intervals of endometrial immune cells during the mid-luteal phaseYu S, Huang C, Lian R, Diao L, Zhang X, Cai S, Wei H, Chen C, Li Y, Zeng Y2023Journal of Reproductive ImmunologyImmunologyClassifier, Multiplex IHCHALO
Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor InfiltratesWei F, Su Y, Quan Y, Li X, Zou Q, Zhang L, Li S, Jiang M, Lin G, Liang P, He J, Xie K2023Clinical Cancer ResearchImmuno-oncologyClassifier, Multiplex IHC, Spatial Analysis, Highplex FLHALO
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancerBancaro N, Cali B, Troiani M, Elia A, Arzola R, Attanasio G, Lai P, Crespo M, Gurel B, Pereira R, Guo C, Mosole S, Brina D, D’Ambrosio M, Pasquini E, Spataro C, Zagato E, Rinaldi A, Pedotti M, Lascio S, Meani F, Montopoli M, Ferrari M, Gallina A, Varani L, Mestre R, Bolis M, Sommer S, de Bono J, Calcinotto A, Alimonti A2023Cancer CellOncologyClassifier, Highplex FLHALO
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockadePai J, Hellmann M, Sauter J, Mattar M, Rizvi H, Woo H, Shah N, Nguyen E, Uddin F, Quintanal-Villalonga A, Chan J, Manoj P, Allaj V, Baine M, Bhanot U, Jain M, Linkov I, Meng F, Brown D, Chaft J, Plodkowski A, Gigoux M, Won H, Sen T, Wells D, Donoghue M, Stanchina E, Wolchok J, Loomis B, Merghoub T, Rudin C, Chow A, Satpathy A2023Cancer CellImmuno-oncologyClassifierHALO
Immune profiling and RNA-seq uncover the cause of partial unexplained recurrent implantation failureFan X, Zhao Q, Li Y, Chen Z, Liao J, Chen H, Meng F, Lu G, Lin G, Gong F2023International ImmunopharmacologyImmunologyClassifier, Multiplex IHCHALO
Targeting the ATF6-mediated ER stress response and autophagy blocks integrin-driven prostate cancer progressionMacke A, Pachikov A, Divita T, Morris M, LaGrange C, Holzapfel M, Kubyshkin A, Zyablitskaya E, Makalish T, Eremenko S, Qiu H, Riethoven J, Hemstreet G, Petrosyan A2023Molecular Cancer ResearchOncologyClassifier, Area Quantification, Multiplex IHC, TMAHALO
Comparing the peri-implantation endometrial T-bet/GATA3 ratio between control fertile women and patients with recurrent miscarriage: establishment and application of a reference range Get access ArrowYu S, Diao L, Lian R, Chen C, Huang C, Li X, Li Y, Zeng Y2023Human ReproductionOtherClassifier, Multiplex IHCHALO
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100Ledermann JA, Shapira-Frommer R, Santin AD, Lisyanskaya AS, Pignata S, Vergote I, Raspagliesi F, Sonke GS, Birrer M, Provencher DM, Sehouli J, Colombo N, González-Martín A, Oaknin A, Ottevanger PB, Rudaitis V, Kobie J, Nebozhyn M, Edmondson M, Sun Y, Cristescu R, Jelinic P, Keefe SM, Matulonis UA2023Gynecologic OncologyImmuno-oncologyClassifier, Highplex FLHALO
Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapiesAdegoke N, Gide T, Mao Y, Quek C, Patrick E, Carlino M, Lo S, Menzies A, da Silva P, Vergara I, Long G, Scolyer R, Wilmott J2023Journal for ImmunoTherapy of CancerImmuno-oncologyClassifier, Highplex FLHALO
Empowering Renal Cancer Management with AI and Digital Pathology: Pathology, Diagnostics and PrognosisIvanova E, Fayzullin A, Grinin V, Ermilov D, Arutyunyan A, Timashev P, Shekhter A2023BiomedicinesReviewClassifier, Area Quantification, Cytonuclear, Object ColocalizationHALO, HALO AI
Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort studyZhou S, Sun D, Mao W, Liu Y, Cen W, Ye L, Liang F, Xu J, Shi H, Ji Y, Wang L, Chang W2023eClinicalMedicineOncologyClassifier, Multiplex IHCHALO
Unaltered hepatic wound healing response in male rats with ancestral liver injuryBeil J, Perner J, Pfaller L, Gérard M, Piaia A, Doelemeyer A, Wasserkrug Naor A, Martin L, Piequet A, Dubost V, Chibout S, Moggs J, Terranova R2023Nature CommunicationsOtherClassifier, Area QuantificationHALO, HALO AI
Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIBPetrova R, Patil AR, Trinh V, McElroy KE, Bhakta M, Tien J, Wilson DS, Warren L, Stratton JR2023Scientific ReportsNeuroscience, MetabolismClassifier, Area Quantification, Object ColocalizationHALO
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor PropertiesWarren M, Matissek S, Rausch M, Panduro M, Hall R, Dulak A, Brennan D, Das Yekkirala S, Koseoglu S, Masia R, Yang Y, Reddy N, Prenovitz R, Strand J, Zaidi T, Devereaux E, Jacoberger Foissac C, Stagg J, Lee B, Holland P, Palombella V, Lake A2023ImmunoHorizonsImmuno-oncologyClassifier, Area Quantification, Multiplex IHCHALO
In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancerMijit M, Kpenu E, Chowdhury N, Gampala S, Wireman R, Liu S, Babb O, Georgiadis M, Wan J, Fishel M, Kelley M2023Redox BiologyOncologyClassifierHALO
Components of the tumor immune microenvironment based on m-IHC correlate with prognosis and subtype of triple-negative breast cancerLin L, Li H, Wang X, Wang Z, Su G, Zhou J, Sun S, Ma X, Chen Y, You C, Gu Y2023Cancer MedicineImmuno-oncologyClassifier, Spatial Analysis, Highplex FLHALO
CD44 expression in renal tubular epithelial cells in the kidneys of rats with cyclosporine-induced chronic kidney diseaseMatsushita K, Toyoda T, Akane H, Morikawa T, Ogawa K2023Journal of Toxicologic PathologyToxicologyClassifierHALO
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinomaSun Y, Wu P, Zhang Z, Wang Z, Zhou K, Song M, Ji Y, Zang F, Lou L, Rao K, Wang P, Gu Y, Gu J, Lu B, Chen L, Pan X, Zhao X, Peng L, Liu D, Chen X, Wu K, Lin P, Wu L, Su Y, Du M, Hou Y, Yang X, Qiu S, Shi Y, Sun H, Zhou J, Huang X, Peng D, Zhang L, Fan J2023Cancer CellOncologyClassifier, Multiplex IHC, Spatial Analysis, Highplex FLHALO
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancerHerzog B, Baer J, Borcherding N, Kingston N, Belle J, Knolhoff B, Hogg G, Ahmad F, Kang L, Petrone J, Lin C, Govindan R, Denardo D2023Science Translational MedicineOncologyClassifier, Multiplex IHCHALO
Analysis of several common APOBEC-type mutations in bladder tumors suggests links to viral infectionRao N, Starrett G, Piaskowski M, Butler K, Golubeva Y, Yan W, Lawrence S, Dean M, Garcia-Closas M, Baris D, Johnson A, Schwenn M, Malats N, Real F, Kogevinas M, Rothman N, Silverman D, Dyrskjøt L, Buck C, Koutros S, Prokunina-Olsson L2023Cancer Prevention ResearchOncologyClassifier, ImmuneHALO
Complex Urban Atmospheres alters Alveolar Stem Cells Niche Properties and drives Lung FibrosisBelgacemi R, Baptista BR, Justeau G, Toigo M, Frauenpreis A, Yilmaz R, Der Vartanian A, Cazaunau M, Pangui E, Bergé A, Gratien A, Macias Rodriguez JC, Bellusci S, Derumeaux G, Boczkowski J, Al Alam D, Coll P, Lanone S, Boyer L2023American Journal of Physiology – Lung Cellular and Molecular PhysiologyFibrosisClassifier, Area Quantification, Highplex FLHALO
The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosisNORBERG S, BAI K, SIEVERS C, ROBBINS Y, FRIEDMAN J, YANG X, KENYON M, WARD E, SCHLOM J, GULLEY J, LANKFORD A, SEMNANI R, SABZEVARI H, BROUGH D, ALLEN C2023Science Translational MedicineOncologyClassifier, Highplex FLHALO
Role of CD44 expressed in renal tubules during maladaptive repair in renal fibrogenesis in an allopurinol-induced rat model of chronic kidney diseaseMatsushita K, Toyoda T, Akane H, Morikawa T, Ogawa K2023Journal of Applied ToxicologyToxicologyClassifierHALO
Exocrine pancreas in type 1 and type 2 diabetes: different patterns of fibrosis, metaplasia, angiopathy, and adiposityWright J, Eskaros A, Windon A, Bottino R, Jenkins R, Bradley A, Aramandla R, Philips S, Kang H, Saunders D, Brissova M, Powers A2023DiabetesGastroenterologyClassifier, Highplex FLHALO
A modified mouse model of Friedreich’s ataxia with conditional Fxn allele homozygosity delays onset of cardiomyopathyPerfitt TL, Huichalaf C, Gooch R, Kuperman A, Ahn Y, Chen X, Ullas S, Hirenallur-Shanthappa D, Zhan Y, Otis D, Whiteley LO, Bulawa C, Martelli A2023American Journal of Physiology-Heart and Circulatory PhysiologyOtherClassifier, Area QuantificationHALO
Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancerVanguri R, Benhamida J, Young J, Li Y, Zivanovic O, Chi D, Snyder A, Hollmann T, Mager K2022Gynecologic Oncology ReportsOncologyClassifierHALO
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergismKrstic J, Reinisch I, Schindlmaier K, Galhuber M, Riahi Z, Berger N, Kupper N, Moyschewitz E, Auer M, Michenthaler H, Nossing C, Repaoli M, Ramadani-Muja J, Usluer S, Stryeck S, Pichler M, Rinner B, Deutsch A, Reinisch A, Madl T, Chiozzi R, Heck A, Huch M, Malli R, Prokesch2022Science AdvancesOncologyClassifierHALO
Therapeutic treatment with the anti-inflammatory drug candidate MW151 may partially reduce memory impairment and normalizes hippocampal metabolic markers in a mouse model of comorbid amyloid and vascular pathologyBraun D, Powell D, McLouth C, Roy S, Watterson D, Van Eldik2022PLOS OneNeuroscienceClassifier, Area QuantificationHALO
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivoKofink C, Trainor N, Mair B, Wrhrle S, Wurm M, Mischerikow N, Bader G, Rumpel K, Gerstberger T, Cui Y, Greb P, Garavel G, Scharnweber M, Fuchs J, Gremel G, Chette P, Hopf S, Budano N, Rinnenthal J, Gmaschitz G, Diers E, McLennan R, Roy M, Whitworth C, Vetma V, Mayer M, Koegl M, Ciulli A, Weinstabl H, Farnaby W2022Nature CommunicationsOncologyClassifierHALO
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 ExpressionCarossino M, Kenney D, O’Connell A, Montarnaro P, Tseng A, Gertje H, Grosz K, Ericsson M, Huber B, Kurnick S, Subramaniam S, Kirkland T, Walker J, Francis K, Klose A, Paragas N, Bosmann M, Saeed M, Balasuriya U, Douam F, Crossland N2022VirusesInfectious DiseaseClassifier, Area Quantification, Highplex FLHALO
Multiplex Immunohistochemical Phenotyping of T Cells in Primary Prostate CancerOzbek B, Ertunc O, Erickson A, Vidal I, Gomes-Alexandre C, Guner G, Hicks J, Jones T, Taube J, Sfanos K, Yegnasubramanian S, DeMarzo A2022The ProstateImmuno-oncologyClassifier, Serial Section, Registration, Figure MakerHALO
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasisChen Z, Zheng L, Chen Y, Liu X, Kawakami M, Mustachi L, Roszik J, Ferry-Galow K, Parchment R, Liu X, Andresson T, Duncan G, Kurie J, Rodriguez-Canales J, Liu X, Dmitrovsky E2022Cancer Biology & TherapyOncologyClassifier, CytonuclearHALO
Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinicTontsch-Grunt U, Traexler P, Baum A, Musa H, Marzin K, Wang S, Trapani F, Engelhardt H, Solca F2022British Journal of CancerOncologyClassifierHALO
3’UTR-directed, kinase proximal mRNA decay inhibits C/EBPβ phosphorylation/activation to suppress senescence in tumor cellsSalotti J, Karim B, Misra S, Hu L, Basu S, Martin N, Luke B, Saylor K, Andresson T, Scheiblin D, Lockett S, Tessarollo L, Johnson P2022bioRxivOncologyClassifier, CytonuclearHALO, HALO AI
Orchestrating the Dermal/Epidermal Tissue Ratio during Wound Healing by Controlling the Moisture ContentTuca A, de Mattos I, Funk M, Winter R, Palackic A, Groeber-Becker F, Kruse D, Kukla F, Lemarchand T, Kamolz L2022BiomedicinesOtherClassifierHALO
Effects of Extracorporeal Shockwave Therapy on Functional Recovery and Circulating miR-375 and miR-382-5p after Subacute and Chronic Spinal Cord Contusion Injury in RatsAshmwe M, Posa K, Ruhrnossl A, Heinzel J, Heimel P, Mock M, Schadl B, Keibl C, Couillard-Despres S, Redl H, Mittermayr R, Hercher D2022BiomedicinesNeuroscience, OtherClassifier, Multiplex IHCHALO
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinomaLu Z, Yang S, Luo X, Shi Y, Lee J, Deva S, Liu T, Chao Y, Zhang Y, Huang R, Xu Y, Shen Z, Shen L2022Gastric CancerImmuno-oncologyClassifier, Multiplex IHCHALO
Prostate cancer androgen receptor activity dictates efficacy of Bipolar Androgen TherapySena L, Kumar R, Sanin D, Thompson E, Rosen D, Dalrymple S, Antony L, Yang Y, Comes-Alexandre C, Hicks J, Jones T, Bowers K, Eskra J, Meyers J, Gupta A, Skaist A, Yegnasubramanian S, Luo J, Brennen W, Kachhap S, Antonarakis E, De Marzo A, Isaacs J, Markowski M, Denmeade S2022medrxivOncologyClassifier, Cytonuclear, Multiplex IHC, RegistrationHALO
Senescence-Associated Molecules and Tumor-Immune-Interactions as Prognostic Biomarkers in Colorectal CancerKellers F, Fernandez A, Konykiewitz B, Schindeldecker M, Tagscherer K, Heintz A, Jesinghaus M, Roth W, Foersch S2022Frontiers in MedicineOncologyClassifierHALO
Chronic rhinosinusitis patients display an aberrant immune cell localisation with enhanced S. aureus biofilm metabolic activity and biomassShaghayegh G, Cooksley C, Bouras G, Panchatcharam B, Idrizi R, Jana M, Ellis S, Psaltis A, Wormald P, Vreugde S2022Journal of Allergy and Clinical ImmunologyImmunology, Infectious DiseaseClassifier, Spatial Analysis, Highplex FLHALO
A survey on artificial intelligence in histopathology image analysisAbdelsamea M, Zidan U, Senousy Z, Gaber M, Rakha E, Ilyas M2022WIREs Data Mining and Knowledge DiscoveryReviewClassifier, CytonuclearHALO
MYC sensitises cells to apoptosis by driving energetic demand.Edwards-Hicks J, Su H, Mangolini M, Yoneten K, Wills J, Rodriguez-Blanco G, Young C, Cho K, Barker H, Muir M, Guerrieri A, Li X, White R, Manasterski P, Mandrou E, Wills K, Chen J, Abraham E, Sateri K, Qian B, Bankhead P, Arends M, Gammoh N, von Kriegsheim A, Patti G, Sims A, Acosta J, Brunton V, Kranc K, Christophorou M, Pearce E, Ringshausen I, Finch A2022Nature CommunicationsOncology, MetabolismClassifierHALO
Glycosphingolipids are mediators of cancer plasticity through independent signaling pathwaysCumin C, Huang Y, Rossdam C, Ruoff F, Cespedes S, Liang C, Lombardo F, Coelho R, Rimmer N, Konantz M, Lopez M, Alam S, Schmidt A, Calabrese D, Fedier A, Vlajnic T, Itzstein M, Templin M, Buettner F, Everest-Dass A, Heinzelmann-Schwarz V, Jacob F2022Cell ReportsOncologyClassifierHALO
Proliferative tumor infiltrating lymphocytes abundance within microenvironment impact clinical outcome in cutaneous B-cell lymphomasMenguy S, Prochazkova-Carolotti M, Azzi-Martin L, Ferte T, Bresson-Bepoldin L, Rey C, Vergier B, Merlio J, Beylot-Barry M, Pham-Ledard A2022Journal of Investigative DermatologyImmuno-oncologyClassifier, Highplex FLHALO
Integrated pathological analysis to develop a Gal-9 based immune survival stratification to predict the outcome of lung large cell neuroendocrine carcinoma and its usefulness in immunotherapyChe Y, Luo Z, Cao Y, Wang J, Xue Q, Sun N, He J2022International Journal of Biological SciencesOncologyClassifier, Multiplex IHCHALO
PD-L1 predicts chemotherapy resistance in large-cell neuroendocrine carcinomaChe Y, Luo Z, Cao Y, Sun N, Xue Q, He J2022British Journal of SurgeryOncologyClassifier, Multiplex IHCHALO
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and densitySomasundaram V, Ridnour L, Cheng R, Walke A, Kedei N, Bhattacharyya D, Wink A, Edmondson E, Butcher D, Warner A, Dorsey T, Scheiblin D, Heinz W, Bryant R, Kinders R, Lipkowitz S, Wong S, Pore M, Hewitt S, McVicar D, Anderson S, Chang J, Glynn S, Ambs S, Lockett S, Wink D2022Redox BiologyOncologyClassifier, RegistrationHALO
Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multimodal ImagingStrittmatter N, Richards F, Race A, Ling S, Sutton D, Nilsson A, Wallez Y, Barnes J, Maglennon G, Gopinathan A, Brais R, Wong E, Serra M, Atkinson J, Smith A, Wilson J, Hamm G, Johnson T, Dunlop C, Kaistha B, Bunch J, Sansom O, Takats Z, Andren P, Lau A, Barry S, Goodwin R, Jodrell D2022Analytical ChemistryOncologyClassifier, Highplex FLHALO, HALO AI
Bone quality and composition are influenced by egg production, layer line, and estradiol-17ß in laying hensEusemann B, Ulrich R, Sacnhez-Rodriquez E, Benavides-Reyes C, Dominguez-Gasca, Rodriguez-Navarro A, Petow S2022Avian PathologyOtherClassifierHALO
Inflammatory Monocytes Promote Granuloma-Mediated Control of Persistent Salmonella InfectionBettke J, Tam J, Montoya V, Butler B, vander Velden A2022Infection and ImmunityInfectious DiseaseClassifier, Area QuantificationHALO
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancerSalome B, Sfakianos J, Ranti D, Daza J, Bieber C, Charap A, Hammer C, Banchereau R, Farkas A, Ruan D, Izadmehr S, Geanon D, Kelly G, Real R, Lee B, Beaumont K, Shroff S, Wang Y, Wang Y, Thin T, Garcia-Barros M, Hegewisch-Solloa E, Mace E, Wang L, O’Donnell T, Chowell D, Fernandez-Rodriguez R, Skobe M, Taylor N, Kim-Schulze S, Sebra R, Palmer D, Clancy-Thompson E, Hammond S, Kamphorst A, Malmberg K, Marcenaro E, Romero P, Brody R, Viard M, Yuki Y, Martin M, Carrington M, Mehrazin R, Wilund P, Mellman I, Mariathasan S, Zhu J, Galsky M, Bhardwaj N, Horowitz A2022Cancer CellOncology, Immuno-oncologyClassifier, Multiplex IHCHALO, HALO AI
Reduced SARS-CoV-2 disease outcomes in Syrian hamsters receiving immune sera: Quantitative image analysis in pathologic assessmentsPieda-Mora C, Robinson S, Tostanoski L, Dayao D, Chandrashekar A, Bauer K, Wrijil L, Ducat S, Hayes T, Yu J, Bondzie E, McMahan K, Sellers D, Giffin V, Hope D, Nampanya F, Mercado N, Kar S, Andersen H, Tzipori S, Barouch D, Martinot A2022Veterinary PathologyInfectious Disease, OtherClassifier, Multiplex IHCHALO
Circulating C-Peptide Levels in Living Children and Young People and Pancreatic Beta Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease DurationCarr A, Inshaw J, Flaxman C, Leete P, Wyatt R, Russell L, Palmer M, Prasolov D, Worthington T, Hull B, Wicker L, Dunber D, Oram R, Morgan N, Toss J, Richardson S, Besser2022DiabetesMetabolismClassifierHALO, HALO AI
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sitesConway J, Rawson R, Lo S, Ahmed T, Veregara I, Gide T, Attrill G, Carlino M, Saw R, Thompson J, Spillane A, Shannon K, Shivalingam B, Menzies A, Wilmott J, Long G, Scolyer R, da Silva I2022Journal for ImmunoTherapy of CancerOncologyClassifier, Spatial AnalysisHALO
Quantitative Dual-Energy Computed Tomography Image Guidance for Thermochemical Ablation: in vivo Results in the Rabbit VX2 ModelThompson E, Fowlkes N, Jacobsen M, Layman R, Cressman E2022Journal of Vascular and Interventional RadiologyOncologyClassifierHALO
Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body RadiotherapyMills B, Qiu H, Drage M, Chen C, Mathew J, Garrett-Larsen J, Ye J, Uccello T, Murphy J, Belt B, Lord E, Katz A, Linehan D, Gerber S2022Clinical Cancer ResearchOncologyClassifier, Spatial Analysis, Highplex FLHALO
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor MicroenvironmentMitchell D, Hunt A, Conrads K, Hood B, Makohon-Moore S, Rojas C, Maxwell G, Bateman N, Conrads T2022JOVEOtherClassifierHALO
A Novel Artificial Intelligence–Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer DriversHuang W, Randhawa R, Jain P, Hubbard S, Eickhoff J, Kummar S, Wilding G, Basu H, Roy R2022JCO Clinical Cancer InformaticsOncologyClassifier, Multiplex IHC, Spatial AnalysisHALO
Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinismWakeling M, Owens N, Hopkinson J, Johnson M, Houghton J, Dastamani A, Flaxman C, Wyatt R, Hewat T, Hopkins J, Laver T, Van Heugten R, Weedon M, De Franco E, Patel K, Ellard S, Morgan N, Cheesman E, Banerjee I, Hattersley A, Dunne M, International Congenital Hyperinsulinism Consortium, Richardson S, Flanagan S2022Nature GeneticsMetabolismClassifier, Highplex FLHALO, HALO AI
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cellsCanellas-Socias A, Cortina C, Hernando-Momblona X, Palomo-Ponce S, Mulholland E, Turon G, Mateo L, Conti S, Roman O, Sevillano M, Slebe F, Stork D, Caballe-Mestres A, Berenguer-Llergo A, Alvarez-Varela A, Fenderico N, Novellasdemunt L, Jimenez-Gracia L, Sipka T, Bardia L, Lorden P, Colombelli J, Heyn H, Trepat X, Tejpar S, Sancho E, Tauriello D, Leedham S, Attolini C, Batlle E2022NatureOncologyClassifier, Highplex FL, RegistrationHALO
The efficacy of a machine learning algorithm for assessing tumour components as a prognostic marker of surgically resected stage IA lung adenocarcinomaTerada Y, Isaka M, Kawata T, Mizuno K, Muramatsu K, Katsumata S, Konno H, Nagata T, Muzuno T, Serizawa M, Ono A, Sugino T, Shimizu K, Ohde Y2022Japanese Journal of Clinical OncologyOncologyClassifierHALO
The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in miceChoi S, Dwyer C, Rapkin L, Cormier M, Hindmarch C, Nesbitt K, Michels A, Hopman W, Swystun L, Lillicrap D2022Journal of Thrombosis and HaemostasisOtherClassifierHALO
Locally confined IFNɣ production by CD4+ T cells provides niches for murine cytomegalovirus
4 replication in the salivary gland
Oderbolz J, Zangger N, Zimmerman L, Sandu I, Starruß J, Graw F, Oxenius A2021bioRxivInfectious DiseaseClassifier, Spatial Analysis, Highplex FLHALO
Fasting reverses drug-resistance in hepatocellular carcinoma through p53-dependent metabolic synergismKrstic J, Reinisch I, Schindlmaier K, Galhuber M, Berger N, Kupper N, Moyschewitz E, Auer M, Michenthaler H, Nössing C, Depaoli MR, Ramadani-Muja J, Stryeck S, Pichler M, Rinner B, Deutsch AJA, Reinisch A, Madl T, Chiozzi RZ, Heck AJR, Huch M, Malli R, Prokesch A2021bioRxivOncologyClassifier, CytonuclearHALO
A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancerHesterberg AB, Rios BL, Wolf EM, Tubbs C, Wong HY, Schaffer KR, Lotan TL, Giannico GA, Gordetsky JB, Hurley PJ2021Journal of Pathology:Clinical ResearchOncologyClassifier, ISH/FISHHALO
CD38 in Advanced Prostate CancersGuo C, Crespo M, Gurel B, Dolling D, Rekowski J, Sharp A, Petremolo A, Sumanasuriya S, Rodrigues DN, Ferreira A, Pereira R, Figueiredo I, Mehra N, Lambros MBK, Neeb A, Gil V, Seed G, Terstappen L, Alimonti A, Drake CG, Yuan W, de Bono JS2021European UrologyOncologyClassifier, Highplex FLHALO
Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cellsNewman AC, Falcone M, Uribe AH, Zhang T, Athineos D, Pietzke M, Vazquez A, Blyth K, Maddocks ODK2021Molecular CellImmuno-oncologyClassifier, ISH/FISHHALO
Activated Regulatory T-Cells, Dysfunctional and SenescentT-Cells Hinder the Immunity in Pancreatic CancerSivakumar S, Abu-Shah E, Ahern DJ, Arbe-Barnes EH, Jainarayanan AK, Mangal N, Reddy S, Rendek A, Easton A, Kurz E, Silva M, Soonawalla Z, Heij LR, Bashford-Rogers R, Middleton MR, DUstin ML2021cancersImmuno-oncologyClassifier, Multiplex IHC, Spatial Analysis, Highplex FLHALO
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinomaKazdal D, Rempel E, Oliveira C, Allgäuer M, Harms A, Singer K, Kohlwes E, Ormanns S, Fink L, Kriegsmann J, Leichsenring M, Kriegsmann K, Stögbauer F, Tavernar L, Leichsenring J, Volckmar A-L, Longuespée R, Winter H, Eichhorn M, Heußel CP, Herth F, Christopoulos P, Reck M, Muley T, Weichert W, Budczies J, Thomas M, Peters S, Warth A, Schirmacher P, Stenzinger A, Kriegsmann M2021Translational Lung Cancer ResearchOncologyClassifier, CytonuclearHALO
TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapyWei Z, Singh O, Ekinci C, Gill J, Li M, Mamatjan Y, Karimi S, Bunda S, Mansouri S, Aldape K, Zadeh G2021Acta Neuropathologica CommunicationsImmunology, NeuroscienceClassifier, Multiplex IHCHALO
Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer TissuesKennedy J, Whiteaker J, Kennedy L, Bosch D, Lerch M, Schoenherr R, Zhao L, Lin C, Chowdhury S, Kilgore M, Allison K, Wang P, Hoofnagle A, Baird G, Paulovich A2021Clinical ChemistryOncologyClassifierHALO
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancyCorreia A Guimaraes J, Auf der Maur P, et al.2021NatureImmuno-oncologyClassifierHALO
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanomaJacquelot N, Seillet C, Wang M et al.2021Nature ImmunologyImmuno-oncologyClassifier, Highplex FLHALO
Cx43 phosphorylation sites regulate pancreatic cancer metastasisSolan JL, Hingorani SR, Lampe PD2021OncogeneOncologyClassifier, Area QuantificationHALO
A comparative study of cirrhosis sub-staging using the Laennec system, Beijing classification, and morphometryZhang X, Schiano T, Doyle E, Branch A, Florman S, Fiel M.2021Modern PathologyMetabolismClassifier, Area QuantificationHALO
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancerWinkler C, King M, Berthe J, Ferraioli D, Garuti A, Grillo F, Rodriguez-Canales J, Ferrando L, Chopin N, Ray-Coquard I, Delpuech O, Bedognetti D, Ballestrero A, Leo E, Zoppoli G2021JCI InsightOncologyClassifier, CytonuclearHALO
Absolute copy number fitting from shallow whole genome sequencing dataSauer C, Eldridge M, Vias M, Hall J, Boyle S, Macintyre G, Bradley T, Markowetz F, Brenton J2021bioRxivOncologyClassifierHALO
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancerSchenk M, Humprey S, Hossain A, Revill M, Pearsall S, Lallo A, Brown S, Bratt S, Galvin M, Descamps T, Zhou C, Pearce S, Priest L, Greenhalgh M, Chaturvedi A, Kerr A, Blackhall F, Dive C, Frese K2021Nature CommunicationsOncologyClassifier, Area QuantificationHALO
Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasisLee B, Hogg E, Below C, Kononov A, Blanco-Gomez A, Heider F, Xu J, Hutton C, Zhang X, Scheidt T, Beattie K, Lamarca A, McNamara M, Valle J, Jorgensen C2021Nature CommunicationsOncologyClassifierHALO
Investigation of Breast Cancer Microstructure and Microvasculature from Time-Dependent DWI and CEST in Correlation with Histological BiomarkersSomeya Y, Iima M, Imai H, Yoshizawa A, Kataoka M, Isoda H, Le Bihan D, Nakamoto Y2021Research SquareOncologyClassifier, Multiplex IHCHALO
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancerVoabil P, de Bruijn M, Roelofsen L, Hendriks S, Brokamp S, van den Braber M, Broeks A, Sanders J, Herzig P, Zippelius A, Blank C, Hartemink K, Monkhorst K, Haanen J, Schumacher T, Thommen D2021Nature MedicineImmuno-oncologyClassifier, Multiplex IHCHALO
spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence dataCreed J, Wilson C, Soupir A, Colin-Leitzinger C, Kimmel G, Ospina O, Chakiryan N, Markowitz J, Peres L, Coghill A, Fridley B2021BioinformaticsOtherClassifierHALO
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinomaVos J, Elbers J, Krijgsman O, Traets J, Qiao X, van der Leun A, Lubeck Y, Seignette I, Smit L, Willems S, van den Brekel M, Dirven R, Karakullukcu B, Karssemakers L, Klop W, Lohuis P, Schreuder W, Smeele L, van der Velden L, Tan I, Onderwater S, Jasperse B, Vogel W, Al-Mamgani A, Keijser A, van der Noort V, Broeks A, Hooijberg E, Peeper D, Schumacher T, Blank C, de Boer J, Haanen J, Zuur C2021Nature CommunicationsOncologyClassifier, Highplex FLHALO
Multiplex Immunohistochemical Phenotyping of T Cells in Primary Prostate CancerOzbek B, Ertunc O, Erickson A, Vidal I, Alexandre C, Guner G, Hicks J, Jones T, Taube J, Sfanos K, Yegnasubramanian S, DeMarzo A2021medRxivImmuno-oncologyClassifier, Cytonuclear, Highplex FL, Serial Section, RegistrationHALO
Mastocytosis-derived extracellular vesicles deliver miR-23a and miR-30a into pre-osteoblasts and prevent osteoblastogenesis and bone formationKim D-K, Bandara G, Cho Y-E, Komarow HD, Donahue DR, Karim B, Baek M-C, Kim HM, Metcalfe DD, Olivera A2021Nature CommunicationsOtherClassifierHALO
Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trialOttolino-Perry K, Shahid A, DeLuca S, Son V, Sukhram M, Meng F, Liu Z, Rapic S, Anantha N, Wang S, Chamma E, Gibson C, Medeiros P, Majeed S, Chu A, Wignall O, Pizzolato A, Rosen C, Teene L, Starr-Dunham D, Kulbatski I, Panzarella T, Done S, Easson A, Leong W, DaCosta R2021Breast Cancer ResearchOncologyClassifier, Area QuantificationHALO
Use of high-rate ventilation results in enhanced recellularization of bio-engineered lung scaffoldsAhmadipour M, Taniguchi D, Duchesneau P, Aoki F, Phillips G, Sinderby C, Waddell T, Karoubi G2021Tissue Engineering Part C: MethodsBiomaterialsClassifier, Multiplex IHCHALO
Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestryZenner M, Helou Y, Deaton R, Sverdlov M, Wang H, Kajdacsy-Balla A, Macias V, Voisine C, Murray M, Abdulkardir S, Murphy A, Nonn L2021The ProstateOncologyClassifier, Area QuantificationHALO
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell CarcinomaStenzel PJ, Schindeldecker M, Teagscherer KE, Foersch S, Herpel E, Hohenfellner M, Hatiboglu G, Alt J, Thomas C, Haferkamp A, Roth W, Macher-Goeppinger S2020Translational OncologyOncology, Immuno-oncologyClassifier, Cytonuclear, TMAHALO
Mechanical regulation of glycolysis via cytoskeleton architecturePark JS, Burckhardt CJ, Lazcano R, Solis LM, Isogai T, Li L, Chen CS, Gao B, Minna JD, Bachoo R, DeBerardinis RJ, Danuser G2020NatureOncologyClassifier, Cytonuclear, TMAHALO
Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole-slide imagesOno A, Terada Y, Kawata T, Serizawa M, Isaka M, Kawabata T, Imai T, Mori K, Muramatsu K, Hayashi I, Kenmotsu H, Oshima K, Urakami K, Nagashima T, Kusuhara M, Akiyama Y, Sugino T, Ohde Y, Yamaguchi K, Takahashi T T2020Cancer MedicineImmuno-oncologyClassifier, Multiplex IHC, Serial SectionHALO
Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21Hussain A, Voisin V, Poon S, Karamboulas C, Bui NHB, Meens J, Dmtryshyn J, Ho VW, Tang KH, Paterson J, Clarke BA, Bernardini MQ, Bader GD, Neel BG,4 Ailles LE2020Journal of Experimental MedicineOncologyClassifier, Area QuantificationHALO
Prognostic value of tumor-infiltrating immune cells in primary colorectal cancer and metastasesMartin SZ, Tagscherer KE, Deckert S, Horst D, Moehler M, Lang H, Roth W2020Research SquareImmuno-oncologyClassifier, CytonuclearHALO
Photoacoustic imaging biomarkers for monitoring biophysical changes during nanobubble-mediated radiation treatmentHysi E, Fadhel MN, Wang Y, Sebastian JA, Giles A, Czarnota GJ, Exner AA, Kolios MC2020PhotoacousticsOtherClassifier, Area Quantification, Object ColocalizationHALO
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphomaRodrigues JM, Hassan M, Freiburghaus C, Eskelund CW, Geisler C, Raty R, Kolstad A, Sundstrom C, Glimelius I, Gronbaek K, Kwiecinska A, Porwit A, Jerkeman M, Ek S2020British Journal of HaematologyOncologyClassifier, CytonuclearHALO
Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Preparations of Lung Cancer: Concordance with Surgical Resections and Technical Validation of CytoLyt® PrefixationLou SK, Ko HM, Kinoshita T, MacDonald S, Weiss J, Czarnecka-Kujawa K, Boerner SL, Yasufuku K, Tsao M-S, Schwock J2020Acta CytologicaOncologyClassifier, MembraneHALO
Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantationKu TJY, Ribeiero RVP, Ferreira VH, Galasso M, Keshavjee S, Kumar D, Cypel M, Humar A2020EBioMedicineOtherClassifier, CytonuclearHALO
Acute Respiratory Distress in Aged, SARS-CoV-2 Infected African Green Monkeys but not Rhesus MacaquesBlair RV, Vaccari M, Doyle-Meyers LA, Roy CJ, Russell-Lodrigue K, Fahlberg M, Monjure CJ, Beddingfield B, Plante KS, Plante JA, Weaver SC, Qin X, Midkiff CC, Lehmicke G, Golden N, Threeton B, Penney T, Allers C, Barnes MB, Pattison M, Datta PK, Maness NJ, Birnbaum A, Fischer T, Bohm RP, Rappaport J2020The American Journal of PathologyInfectious DiseaseClassifierHALO
Immuno-Interface Score to Predict Outcome in
Colorectal Cancer Independent of Microsatellite
Instability Status
Nestarenkaite A, Fadhil W, Ramusson A, Susanti S, Hadjimichael E, Laurinaviciene A, Ilyas M, Laurinavicius A2020CancersImmuno-oncologyClassifier, Multiplex IHCHALO
SLFN11 informs on standard of care and novel treatments in a wide range of cancer modelsWinkler C, Armenia J, Jones GN, Tobalina L, Sale MJ, Petreus T, Baird T, Serra V, Wang AT, Lau A, Garnett MJ, Jaaks P, Coker EA, Pierce AJ, O’Connor MJ, Leo E2020British Journal of CancerOncologyClassifier, CytonuclearHALO
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosaReyes-Uribe L, Wu Wenhui, Gelincik O, Bommi P, Francisco-Cruz A, Solis L, Lynch P, Lim R, Stoffel E, Kanth P, Samadder N, Mork M, Taggart M, Milne G, Marnett L, Vornik L, Liu D, Revuelta M, Chang K, You Y, Kipelovich L, Wistuba I, Lee J, Sei S, Shoemaker R, Szabo E, Richmond E, Umar A, Perloff M, Brown P, Lipkin S, Vilar E2020The BMJOncology, GastroenterologyClassifier, CytonuclearHALO
A preclinical trial and molecularly-annotated patient cohort identify predictive biomarkers in homologous recombination deficient pancreatic cancerWang Y, Park J, Pacis A, Denroche R, Jang G, Zhang A, Cuggia A, Domecq C, Monlong J, Raitses-Gurevich M, Grant R, Borgida A, Holter S, Stossel C, Bu S, Masoomian M, Lungu I, Bartlett J, Wilson J, Gao Z, Riazalhosseini Y, Asselah J, Bouganim N, Cabrera T, Boucher L, Valenti D, Biagi J, Greenwood C, Polak P, Foulkes W, Golan T, O’Kane G, Fischer S, Knox J, Gallinger S, Zogopoulos G2020Clinical Cancer ResearchOncologyClassifier, Cytonuclear, Multiplex IHCHALO
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trialvan Dijk N, Gil-Jimenez A, Silina K, Hendricksen K, Smit LA, de Feijter JM, van Montfoort ML, van Rooijen C, Peters D, Broeks A, van der Poel HG, Bruining A, Lubeck Y, Sikorska K, Boellaard TN, Kvistborg P, Vis DJ, Hooijberg E, Schumacher TN, van den Broek M, Wessels LFA, Blank CU, van Rhijn BW, van der Heijden MS2020Nature MedicineImmuno-oncologyClassifier, Highplex FLHALO
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitisLi L, Wu Z, Qiu X, Wu Y, Kuang Z, Wang L, Sun T, Liu Y, Yi S, Jing H, Zhou S, Chen B, Wu, D, Wu W, Liu J2020International ImmunopharmacologyImmunology, DermatologyClassifierHALO
PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancerMartell K, McIntyre JB, Kornaga EN, Chan AMY, Phan T, Kobel M, Enwere EK, Dean ML, Ghatage P, Lees-Miller SP, Doll CM2020Gynecologic OncologyOncologyClassifier, Highplex FL, TMAHALO
Association between CD8 and PD‐L1 expression and outcomes after radical prostatectomy for localized prostate cancerVicier C, Ravi P, Kwak L, Werner L, Huang Y, Evan C, Loda M, Hamid AA, Sweeney CJ2020The ProstateImmuno-oncologyClassifier, Highplex FLHALO
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosaReyes-Uribe L, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, Vornik L, Liu DD, Revuelta M, Chang K, You YN, Kopelovich L, Wistuba II, Lee JJ, Sei S, Shoemaker RH, Szabo E, Richmond E, Umar A, Perloff M, Brown PH, Lipkin SM, Vilar E2020GutOncologyClassifier, CytonuclearHALO
Tumor vessel normalization, immuno-stimulatory reprogramming, and improved survival in glioblastoma with combined inhibition of PD-1, angiopoietin-2, and VEGFDi Tacchio M, Macas J, Weissenberger J, Sommer K, Bähr O, Steinbach JP, Senft C, Seifert V, Glas M, Herrlinger U, Krex D, Meinhardt M, Weyerbrock A, Timmer M, Goldbrunner R, Deckert M, Scheel AH, Büttner R, Grauer OM, Schittenhelm J, Tabatabai G, Harter PN, Guenther S, Devraj K, Plate KH, Reiss Y2020Cancer Immunology ResearchOncology, Immuno-oncologyClassifier, CytonuclearHALO
Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patientsNearchou IP, Gwyther BM, Georgiakakis ECT, Gavriel CG, Kajiwara Y, Ueno H, Harrison DJ, Caie PD2020Digital MedicineImmuno-oncologyClassifier, Area Quantification, Spatial AnalysisHALO
Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancerMartin SZ, Wagner DC, Hörner N, Horst D, Lang H, Tagscherer KE, Roth W2019BMC CancerOncologyClassifier, CytonuclearHALO
Magnetic Resonance Imaging as a Biomarker in Rodent Peripheral Nerve Injury Models Reveals an Age-Related Impairment of Nerve RegenerationGiorgetti E, Obrecht M, Ronco M, Panesar M, Lambert C, Accart N, Doelemeyer A, Nash M, Bidinosti M, Beckmann N2019Scientific ReportsNeuroscienceClassifierHALO
Quantification of histopathological findings using a novel image analysis platformHorai Y, Mizukawa M, Nishina H, Nishikawa S, Ono Y, Takemoto K, Baba N2019Journal of Toxicologic PathologyToxicologyClassifierHALO
Detection of Lung Cancer Lymph Node Metastases from Whole-Slide Histopathologic Images Using a Two-Step Deep Learning ApproachPham HHN, Futakuchi M, Bychkov A, Furukawa T, Kuroda K, Fukuoka J2019The American Journal of PathologyOncologyClassifierHALO, HALO AI
Modulation of Microglia by Voluntary Exercise or CSF1R Inhibition Prevents Age-Related Loss of Functional Motor UnitsGiorgetti E, Panesar M, Zhang Y, Joller S, Ronco M, Obrecht M, Lambert C, Accart N, Beckmann N, Doelemeyer A, Perrot L, Fruh I, Mueller M, Pierrel E, Summermatter S, Bidinosti M, Shimshek DR, Brachat S, Nash M2019Cell ReportsNeuroscienceClassifier, CytonuclearHALO
Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutationsOno Y, Yamazaki Y, Omata K, Else T, Tomlins SA, Rhayem Y, Williams TA, Reincke M, Carling T, Monticone S, Mulatero P, Beuschlein F, Ito S, Satoh F, Rainey WE, Sasano H2019The Journal of Clinical Endocrinology & MetabolismOncologyClassifier, Area QuantificationHALO
Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinomaYoung RJ, Bressel M, Porceddu S, Cernelc J, Savas P, Liu H, Urban D, Thai AA, Cooper C, Fua T, Neeson P, Rischin D, Solomon B2019Oral OncologyOncology, Infectious DiseaseClassifier, Highplex FLHALO
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLCKargl J, Zhu X, Zhang H, Yang GHY, Friesen TJ, Shipley M, Maeda DY, Zebala JA, McKay-Fleisch J, Meredith G, Mashadi-Hossein A, Baik C, Pierce RH, Redman MW, Thompson JC, Albelda SM, Bolouri H, Houghton AM2019JCI InsightImmuno-oncologyClassifier, Highplex FLHALO
MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancerGreer YE, Gilbert SF, Gril B, Narwal R, Brooks DLP, Tice DA, Steeg PS, Lipkowitz2019Breast Cancer ResearchOncologyClassifierHALO
Precision immunoprofiling by image analysis and artificial intelligenceKoelzer VH, Sirinukunwattana K, Rittscher J, Mertz KD2019Vichows ArchivReviewClassifier, Multiplex IHC, Spatial AnalysisHALO
Impact of pre‐therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV‐specific T‐cell therapyWalker DG, Shakya R, Morrison B, Neller MA, Matthews KK, Nicholls J, Smith C, Khanna R2019Clinical & Translational ImmunologyImmuno-oncologyClassifierHALO
Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesityPetkevicius K, Virtue S, Bidault G, Jenkins B, Cubuk C, Morgantini C, Aouadi M, Dopazo J, Serlie M, Koulman A, Vidal-Puig A2019ElifeImmunologyClassifier, VacuoleHALO, HALO AI
Detection of Lung Cancer from Whole-Slide Histopathologic Images Using Deep Learning ApproachMishra N, Behera P, Nanda R, Sahoo M2019International Journal of Research in Engineering and SciencesOncologyClassifierHALO, HALO AI
Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer’s disease patient brain samplesProkop S, Miller KR, Labra SR, Pitkin RM, Hoxha K, Narasimhan S, Changolkar L, Rosenbloom A, Lee VM-Y, Trojanowski JQ2019Acta NeuropathologicaNeuroscienceClassifier, Area QuantificationHALO
Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancerAbe N, Matsumoto H, Takamatsu R, Tamaki K, Takigami N, Uehara K, Kamada Y, Tamaki N, Motonari T, Unesoko M, Nakada N, Zaha N, Zaha H, Yoshimi N2019Vichows ArchivOncologyClassifier, CytonuclearHALO
Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21Hussain A, Voisin V, Poon S, Dmytryshyn J ,Richman C, Meens J, Ho VW, Tang KH, Paterson J, Clarke B, Bernardini M, Bader G, Neel B, Ailles L2019Journal of Experimental MedicineOncologyClassifier, Area QuantificationHALO
Cognitive and Pathological Influences of Tau Pathology in Lewy Body DisordersCoughlin DG, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig H, Coslett HB, Hamilton R, Siderowf A, Duda JE, Rascovsky K, Lee EB, Lee VM-Y, Grossman M, Trojanowski JQ, Irwin DJ2019Annals of NeurologyNeuroscienceClassifier, Area QuantificationHALO
Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancerGhaffari A, Hoskin V, Turashvili G, Varma S, Mewburn J, Mullins G, Greer PA, Kiefer F, Day AG, Madarnas Y, SenGupta S, Elliott BE2019Breast Cancer ResearchOncologyClassifier, CytonuclearHALO
Islet amyloidosis in a child with type 1 diabetesBeery ML, Jacobsen LM, Atkinson MA, Butler AE, Campbell-Thompson M2019IsletsMetabolismClassifierHALO
Machine learning approaches for pathologic diagnosisKomura D, Ishikawa S2019Vichows ArchivReviewClassifierHALO, HALO AI
Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About
Ready for Prime-Time?
Hofman P, Badoual C, Henderson F, Berland L, Hamila M, Long-Mira E, Lassalle S, Roussel H, Hofman V, Tartour E, Ilié M2019CancersOncology, Immuno-oncology, ReviewClassifier, Multiplex IHCHALO
MYB-NFIB gene fusions identified in archival adenoid cystic carcinoma tissue employing NanoString analysis: an exploratory studyMcIntyre JB, Ko JJ, Siever J, Chan AMY, Simpson RHW, Hao D, Lau HY2019Diagnostic PathologyOncologyClassifier, Highplex FLHALO
Predicting breast cancer response to neoadjuvant chemotherapy based on tumor vascular features in needle biopsiesBrocato TA, Brown-Glaberman U, Wang Z, Selwyn RG, Wilson CM, Wyckoff EF, Lomo LC, Saline JL, Hooda-Nehra A, Pasqualini R, Arap W, Brinker CJ, Cristini V2019JCI InsightOncologyClassifierHALO
A Dual Blocker of Endothelin A/B Receptors Mitigates Hypertension but not Renal Dysfunction in a Rat Model of Chronic Kidney Disease and Sleep ApneaMorales-Loredo H, Jones DT, Barrera A, Mendiola P, Garcia J, Pace CE, Murphy M, Kanagy NL, Gonzalez Bosc LV2019American Journal of Physiology-Renal PhysiologyMetabolismClassifier, Cytonuclear, Figure MakerHALO
Ultrasensitive automated RNA in situ hybridization for kappa and lambda light chain mRNA detects B-cell clonality in tissue biopsies with performance comparable or superior to flow cytometryGuo L, Wang Z, Anderson CA, Doolittle E, Kernag S, Cotta CV, Ondrejka SL, Ma X-J, Cook JR2018Modern PathologyOtherClassifier, ISH/FISHHALO
pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistryJones GN, Rooney C, Griffin N, Roudier M, Young LA, Garcia-Trinidad A, Hughes GD, Whiteaker JR, Wilson Z, Odedra R, Zhao L, Ivey RG, Howat WJ, Harrington EA, Carrett JC, Ramos-Montoya A, Lau A, Paulovich AG, Cadogan EB, Pierce AJ2018British Journal of CancerOncologyClassifier, CytonuclearHALO
A suboptimal maternal diet combined with accelerated postnatal growth results in an altered aging profile in the thymus of male ratsTarry-Adkins JL, Aiken CE, Ashmore TJ, Fernandez-Twinn DS, Chen J-H, Ozanne SE2018The FASEB JournalNeuroscience, MetabolismClassifier, VacuoleHALO
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA mutated breast cancerCruz C, Castroviejo-Bermejo M, Gutiérrez-Enríquez S, Llop-Guevara A, Ibrahim YH, Gris-Oliver A, Bonache S, Morancho B, Bruna A, Rueda OM, Lai Z, Polanska UM, Jones GN,Kristel P, de Bustos L, Guzman M, Rodriguez O, Grueso J, Montalban G, Caratú G, Mancuso F, Fasani R, Jiménez J, Howat WJ, Dougherty B, Vivancos A, Nuciforo P, Serres-Créixams X, Rubio IT, Oaknin A, Cadogan O, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Arribas J, Jonkers J, Díez O, O’Connor MJ, Balmaña J, SerraV2018Annals of OncologyOncologyClassifier, CytonuclearHALO
Biomarker Evaluation and Toxic Effects of an Acute Oral and Systemic Fumonisin Exposure of Pigs with a Special Focus on Dietary Fumonisin Esterase SupplementationSchertz H, Danicke S, Frahm J, Schatzmayr D, Dohnal I, Bichl G, Schwartz-Zimmerman HE, Colicchia S, Breves G, Teifke JP, Kluess J2018ToxinsToxicologyClassifierHALO
Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survivalLogsdon DP, Fenil S, Fabrizio C, Supuran CT, Kamocka M, Jacobsen MH, Sandusky GE, Kelley MR, Fishel ML2018Scientific ReportsOncologyClassifier, CytonuclearHALO
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activityFreiburghaus C, Emruli VK, Johansson A, Eskelund CW, Grønbæk K, Olsson R, Ek F, Jerkeman M, Ek S2018BMC CancerOncologyClassifier, CytonuclearHALO
Digital image analysis improves precision of PD‐L1 scoring in cutaneous melanomaKoelzer VH, Gisler A, Hanhart JC, Griss J, Wagner SN, Willi N, Cathomas G, Sachs M, Kempf W, Thommen DS, Mertz KD2018HistopathologyOncology, Immuno-oncologyClassifier, Multiplex IHCHALO
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter‑platform agreementKoopman T, Buikema HJ, Hollema H, de Bock GH, van der Vegt B2018Breast Cancer Research and TreatmentOncologyClassifier, CytonuclearHALO
Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and humanPognan F, Mahl JA, Papoutsi M, David Ledieu D, Raccuglia M, Theil D, Voytek SB, Devine PJ, Kubek‑Luck K, Claudio N, Cordier A, Heier A, Kolly C, Hartmann A, Chibout S-D, Bouchard P, Trendelenburg C2018Archives of ToxicologyToxicologyClassifier, CytonuclearHALO
Intermittent Hypoxia Exacerbates Increased Blood Pressure in Rats with Chronic Kidney DiseaseRiggs J, Pace C, Ward HH, Gonzalez Bosc L, Rios L, Barrera A, Kanagy NL2018American Journal of Physiology-Renal PhysiologyMetabolismClassifier, CytonuclearHALO
Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPaseHudson LG, Gillette JM, Kang H, Rivera MR, Wandinger-Ness A2018CancersReviewClassifier, Cytonuclear, Figure MakerHALO
The novel ATM inhbitior (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan montherapyGreene J, Nguyen A, Bagby SM, Jones GN, Tai WM, Quackenbush KS, Schreiber A, Messersmith WA, Devaraj KM, Blatchford P, Eckhardt SG, Cadogan EB, Hughes GD, Smith A, Pitts TM, Arcaroli JJ2018OncotargetOncologyClassifier, Area Quantification, CytonuclearHALO
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor modelsDurant ST, Zheng L, Wang Y, Chen K, Zhang L, Zhang T, Yang Z, Riches L, Trinidad AG, Fok JHL, Hunt T, Pike KG, Wilson J, Smith A, Colclough N, Reddy VP, Sykes A, Janefeldt A, Johnström P, Varnäs K, Takano A, Ling S, Orme J, Stott J, Roberts C, Barrett I, Jones G, Roudier M, Pierce A, Allen J, Kahn J, Sule A, Karlin J, Cronin A, Chapman M, Valerie K, Illingworth R, Pass M2018Science AdvancesOncology, NeuroscienceClassifier, CytonuclearHALO
Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancerOsman J, Savari S, Chandrashekar NK, Bellamkonda K, Souglas D, Sjolander A2017OncotargetOncology, ImmunologyClassifier, Area QuantificationHALO
Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator studyAcs B, Pelekanou V, Bai Y, Martinez-Morilla S, Toki M, Leung SCY, Nielsen TO, Rimm DL2017Laboratory InvestigationsOncologyClassifier, CytonuclearHALO
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplificationVan Cutsem E, Bang Y-J, Mansoor W, Petty RD, Chao Y, Cunningham D, Ferry DR, N. R. Smith NR, Frewer P, Ratnayake J, Stockman PK, Kilgour E, and Landers D2017Annals of OncologyOncologyClassifier, ISH/FISHHALO
An ancestral retroviral protein identified as a therapeutic target in type-1 diabetesLevet S, Medina J, Joanou J, Demolder A, Queruel N, Réant K, Normand M, Seffals M, Dimier J, Germi R, Piofczyk T, Portoukalian J, Touraine J-L, Perron H2017JCI InsightImmunology, MetabolismClassifier, CytonuclearHALO
cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic OsteosarcomaHe Y, Zhu W, Shin MH, Gary J, Liu C, Dubois W, Hoover SB, Jiang S, Marrogi E, Mock B, Simpson RM, and Huang J2017Stem Cell ReportsOncologyClassifierHALO
DPP9 enzyme activity controls survival of mouse migratory tongue muscle progenitors and its absence leads to neonatal lethality due to suckling defectKim M, Minoux M, Piaia A, Kueng B, Gapp B, Weber D, Haller C, Barbieri S, Namoto K, Lorenz T, Wirsching J, Bassilana F, Dietrich W, Rijli FM, Ksiazek I2017Developmental BiologyMyologyClassifier, Area QuantificationHALO
Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancerChanda A, Chan A, Deng L, Kornaga EN, Enwere EK, Morris DG, Bonni S2017PLOS OneOncologyClassifier, CytonuclearHALO
In vivo characterization of a new type of biodegradable starch microsphere for transarterial embolizationSommer CM, Do TD, Schlett CL, Flechsig P, Gockner TL, Kuthning A, Vollherbst DF, Pereira PL, Kauczor HU, Macher-Göppinger S2017Journal of Biomaterials ApplicationsOncologyClassifierHALO
The R-enantiomer of ketorolac delays mammary tumor development in mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) miceAS Peretti, D Dominguez, MM Grimes, HJ Hathaway, ER Prossnitz, MR Rivera, A Wandinger-Ness, D Kusewitt, LG Hudson2017The American Journal of PathologyOncologyClassifier, Area Quantification, CytonuclearHALO
A Phase II Trial of Dovitinib in BCD-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Over-Expression: Hoosier Cancer Research Network Trial HCRN 12-157Hahn NH, Bivalacqua TJ, Ross AE, Netto GJ, Baras AS, Park JC, Chapman C, Masterson TA, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Jones DR, Kyle McElyea K, Sandusky GE, Breen T, Liu Z, Albany C, Moore ML, Loman RA, Reed A, Turner SA, de Abreu FB, Gallagher TL, Tsongalis GJ, Plimack ER, Greenberg RE, Geynisman DM2016Clinical Cancer ResearchOncologyClassifier, CytonuclearHALO
Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinomaLaurinavicius A, Plancoulaine B, Rasmusson A, Besusparis J, Augulis R, Meskauskas R, Herlin P, Laurinaviciene A, Muftah AAA, Miligy I, Aleskandarany M, Rakha EA, Green AR, Ellis IO2016Virchows ArchivOncologyClassifier, CytonuclearHALO
Efficient recovery of potent tumour-infiltrating lymphocytes through quantitative immunomagnetic cell sortingWang Z, Ahmed S, Labib M, Wang H, Hu X, Wei J, Yao Y, Moffat J, Sargent E, Kelley S2022Nature Biomedical EngineeringImmuno-oncologyClassifier, CytonuclearHALO
Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organizationDinevska M, Widodo S, Furst L, Cuzcano L, Fang Y, Mangiola S, Neeson P, Darcy P, Ramsay R, Hutchinson R, MacKay F, Christie M, Stylli S, Mantamadiotis T2022Cellular OncologyOncologyClassifier, Highplex FL, RegistrationHALO

Related HALO Modules

Highplex FL

Quantify expression of an unlimited number of biomarkers in any cellular compartment - membrane, nucleus or cytoplasm.

Learn More
Multiplex IHC

Quantify expression of up to five brightfield stains in any cellular compartment - membrane, nucleus or cytoplasm.

Learn More
Spatial Analysis

Plot cells and objects from one or more images and perform nearest neighbor analysis, proximity analysis, and tumor infiltration analysis.

Learn More

Use the arrows above to view additional related modules

Want to Learn More?

Fill out the form below to request information about any of our software products.
You can also drop us an email at info@indicalab.com

Products & Services

Interested in purchasing or learning more about our products and services? Our highly trained application scientists are a couple of clicks away.

Software Maintenance & Support Coverage

Interested in purchasing an SMS plan? We would be happy to give you a quote.

Technical Support 

Need technical support? Our IT specialists are here to help.

We highly recommend using Google Chrome when filling out the form above. Please email marketing@indicalab.com for support.
Scroll to Top